Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates |
| |
| Institution: | 1. College of Chemistry & Chemical Engineering, Yangzhou University, Yangzhou 225002, PR China;2. Yangzhou Polytechnic Institute, Yangzhou 225127, PR China;1. School of Pathology and Laboratory Medicine, University of Western Australia, Australia;2. Department of Microbiology and Infectious Disease, Royal Perth Hospital, Australia;3. Institute of Human Virology and Cancer Biology, University of Indonesia, Indonesia;4. School of Medicine, University of Indonesia/Cipto Mangunkusumo Hospital, Indonesia |
| |
| Abstract: | Asthma, chronic obstructive pulmonary disease (COPD) and acute lung injury/acute respiratory distress syndrome (ALI/ARDS) are characterized by neutrophilic inflammation and elevated levels of leukotriene B4 (LTB4). However, the exact role of LTB4 pathways in mediating pulmonary neutrophilia and the potential therapeutic application of LTB4 receptor antagonists in these diseases remains controversial. Here we show that a novel dual BLT1 and BLT2 receptor antagonist, RO5101576, potently inhibited LTB4-evoked calcium mobilization in HL-60 cells and chemotaxis of human neutrophils. RO5101576 significantly attenuated LTB4-evoked pulmonary eosinophilia in guinea pigs. In non-human primates, RO5101576 inhibited allergen and ozone-evoked pulmonary neutrophilia, with comparable efficacy to budesonide (allergic responses). RO5101576 had no effects on LPS-evoked neutrophilia in guinea pigs and cigarette smoke-evoked neutrophilia in mice and rats. In toxicology studies RO5101576 was well-tolerated. Theses studies show differential effects of LTB4 receptor antagonism on neutrophil responses in vivo and suggest RO5101576 may represent a potential new treatment for pulmonary neutrophilia in asthma. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
